Financhill
Back

Adaptimmune Therapeutics PLC Vs. NuCana PLC Industry Stock Comparison

Sell
30

ADAP
Adaptimmune Therapeutics PLC

Last Price:
0.85
Seasonality Move:
40.93%
Sell
40

NCNA
NuCana PLC

Last Price:
1.55
Seasonality Move:
11.02%
Sell
30
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.83. The Score for ADAP is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
NuCana PLC (NCNA) is a Sell

Is NuCana PLC a Buy, Sell or Hold?

  • The current NuCana PLC [NCNA] share price is $1.53. The Score for NCNA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • NCNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

  • The Adaptimmune Therapeutics PLC share price today is $0.83
    The current trend is relatively stagnant and ADAP is experiencing buying pressure, which is a positive indicator for future bullish movement.

NCNA Stock Price Chart

What is NuCana PLC's stock price today?

  • The NuCana PLC share price today is $1.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NCNA is experiencing selling pressure, which indicates risk of future bearish movement.

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 48.33 Sell
Chaikin Money Flow: 444283 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.76 - 0.9) Sell
Bollinger Bands (100): (0.87 - 1.21) Sell

NCNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.33 Sell
Relative Strength Index (14 RSI): 33.22 Sell
Chaikin Money Flow: -66196 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.68 - 2.06) Sell
Bollinger Bands (100): (1.61 - 4.93) Sell

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.76 Buy
20-day SMA: 0.81 Buy
50-day SMA: 0.96 Sell
200-day SMA: 1.13 Sell
8-day EMA: 0.78 Buy
20-day EMA: 0.82 Buy
50-day EMA: 0.91 Sell
200-day EMA: 1.03 Sell

NCNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.66 Sell
20-day SMA: 1.84 Sell
50-day SMA: 2.85 Sell
200-day SMA: 4.63 Sell
8-day EMA: 1.64 Sell
20-day EMA: 1.89 Sell
50-day EMA: 2.57 Sell
200-day EMA: 5.41 Sell

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.

NuCana PLC Earnings Growth & NCNA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.56 per share, and an increase next year of $0.19 per share.

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NuCana PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):